Incubation of normal mouse splenic lymphocytes with dimeric mouse IgD results in the formation of T-cell factors that selectively inhibit rosette formation ofFc6 receptorpositive lymphocytes with IgD-coated erythrocytes. 
Previous studies by several investigators established the presence of T-cell factors having affinity for one of the immunoglobulin isotypes, such as IgG, IgE, or IgA (1-3). The formation of the immunoglobulin-binding factors (Ig-BF) can be induced by incubation of lymphocytes with immunoglobulin of the respective isotype (2) (3) (4) , and the factors are believed to be related to Fc receptors (FcR) for the respective isotype (5) . Indeed, a monoclonal antibody against rat IgE-BF crossreacted with FcR on both T and B cells (6) . Coico et al. (7) reported that a subset of mouse T cells expressed FcR specific for IgD (Fc8R) and that the proportion of FcsR+ cells in a normal spleen cell suspension increased upon incubation of the cells with IgD. In view of these findings, the present experiments were undertaken to determine whether mouse T cells produce soluble factors having affinity for IgD (i.e., IgD-BF). Since IgE-BF and IgG-BF could be detected by their ability to inhibit rosette formation of FcR' cells and FcR+ cells, respectively (2, 8) , we assessed the presence of IgD-BF by the ability of culture filtrates to inhibit rosette formation of Fc&R' lymphocytes with IgD-coated ox erythrocytes. The results show that mouse Lyt-1+ T cells form IgD-BF upon incubation with dimeric mouse IgD.
MATERIALS AND METHODS
Immunoglobulins and Antibodies. Monoclonal mouse IgD was obtained from ascitic fluid of BALB/c mice that had been injected with plasmacytoma TEPC-1017 (9) and was isolated by the method of Finkelman et al. (9) with slight modifications. Briefly, proteins were precipitated with 50% saturated ammonium sulfate, and the precipitate fraction was further fractionated by chromatography on a DE-52 column (Whatman). Proteins eluted with 0.1 M Tris/HCl buffer (pH 8.2) were then applied to an Ultrogel AcA 34 (LKB) column. IgD was eluted as a single peak shortly after the void volume, and the purified IgD contained no other immunoglobulin. Purified mouse IgE from hybridoma H1-DNP-E-26 (10) , monoclonal rat IgE from immunocytoma IR 162, and normal rabbit IgG were the same preparations as those previously described (8) . Normal mouse IgG2 was obtained by DEAEcellulose column chromatography. MOPC-21 IgG1 myeloma protein was obtained from Bionetics (Charleston, SC). Each immunoglobulin was coupled to Sepharose CL-4B: 5-8 mg of protein was coupled to 1 ml of Sepharose.
Goat anti-mouse IgD antibodies were kindly supplied by F. D. Finkelman (Uniformed Services University of the Health Sciences, Bethesda, MD). Specifically purified antimouse immunoglobulin antibodies was the same preparation as that previously described (8) . Monoclonal anti-Thy-1, anti-Lyt-1.2, and anti-Lyt-2.2 antibodies were purchased from New England Nuclear. Fluorescein-conjugated rat monoclonal anti-Lyt-1 (53-7.3) and anti-Lyt-2 (53-6.7) antibodies were purchased from Becton Dickinson (Mountain View, CA). A rabbit antiserum against mouse brain (antibrain 6) was described previously (11) . Fluorescein-conjugated goat anti-mouse immunoglobulins and anti-rabbit IgG were purchased from Meloy Laboratories (Springfield, VA).
Mouse Spleen Cells and Cell Fractionation. BALB/c mice were purchased from Charles River Breeding Laboratories (Wilmington, MA). Normal splenic lymphocytes were obtained by passing a spleen cell suspension through a Sephadex G-10 column. T cells or their subpopulations in splenic lymphocytes were depleted by using monoclonal anti-Thy-1, anti-Lyt-1.2, and anti-Lyt-2.2 antibodies together with rabbit complement (8) . A T-cell-enriched fraction was obtained from splenic lymphocytes by depleting B cells by means of tissue culture dishes coated with the F(ab')2 fragments of anti-mouse immunoglobulin (12 Ig-BF were detected by rosette inhibition. Culture supernatants were filtered through Diaflo YM100 membranes (Amicon), and the filtrates were concentrated 3-to 5-fold. Thirty microliters of the filtrate was added to 15 ,ul of a 2% (vol/vol) suspension of indicator cells and the mixture was incubated for 30 min at 4°C. Fifteen microliters of a lymphocyte suspension (107 cells per ml) was then added to the mixture and rosette formation was examined as described above.
Source of IgE-BF and IgG-BF. The factors were obtained from a mouse T-cell hybridoma, 231F1 (8) . The hybridoma cells were incubated for 24 hr with syngeneic macrophages that had been exposed to ovalbumin, and culture supernatants were filtered through YM100 membranes.
Fractionation of Ig-BF. IgD-BF, IgE-BF, and IgG-BF were purified using mouse IgD-Sepharose, rat IgE-Sepharose, and rabbit IgG-Sepharose, respectively, by the procedures previously described (16) . Briefly, culture filtrates were mixed with Ig-coupled Sepharose for 90 min, and the suspension then was packed into a small column. The beads were washed with DPBS, and bound material was eluted with glycine/HCl buffer (pH 3.0).
The molecular weight of IgD-BF was estimated by gel filtration through a TSK G3000 SWG column that had been calibrated with lactate dehydrogenase, bovine serum albumin, ovalbumin, chymotrypsinogen, and cytochrome c. A one-milliliter sample was applied to the column, and proteins were eluted with DPBS, using a high-performance liquid chromatography system (Waters Associates).
RESULTS
Detection of IgD-BF. In preliminary experiments, fixed ox erythrocytes (E') were treated with IgD at 0.25-1.25 mg/ml to prepare indicator cells, and the proportion of RFCs in normal splenic lymphocytes was determined. Repeated experiments showed that E' treated with IgD at 1.25 mg/ml gave the most consistent results. With these indicator cells, 20-27% of normal splenic lymphocytes formed rosettes. To determine the specificity of rosette formation, normal lymphocytes were suspended with mouse immunoglobulins of various isotypes and then were fixed with the indicator cells (Table 1) . IgD at 50 ,ug/ml markedly inhibited rosette formation, and IgD at 1 mg/ml inhibited the rosettes almost completely. In contrast, IgG1, IgG2, or IgE at 1 mg/ml failed to affect the proportion of RFCs. These results showed that rosetting of lymphocytes with E'-IgD is specific for IgD.
Since Coico et al. (7) reported that the proportion of IgD-RFCs in normal lymphocytes increased after exposure of We then determined whether IgD might induce the formation of IgD-BF. Aliquots of a suspension of normal splenic lymphocytes (107 nucleated cells per ml) were incubated overnight with 0.1-0.4 ug of mouse IgD per ml or in the absence of the protein. Culture filtrates then were concentrated 5-fold, and an aliquot of each sample was assessed for the ability to inhibit rosette formation of normal lymphocytes with E'-IgD (Table 2 ). Culture filtrate of IgD(+) culture markedly inhibited the formation of IgD rosettes, while that of IgD(-) culture failed to do so. We wondered whether the rosette inhibiting factor might have affinity for IgD. When an aliquot of the culture filtrates was fractionated on IgDSepharose, the rosette-inhibiting factor was adsorbed to IgD-Sepharose and recovered by elution of the beads at acid pH. When the same culture filtrate was fractionated on IgG-Sepharose or IgE-Sepharose, the rosette-inhibiting factor was detected in the effluent fractions ( The molecular weights of IgD-BF were estimated by gel filtration. Splenic lymphocytes were incubated with IgD (0.4 ,g/ml) for 24 hr, and IgD-BF in culture filtrates were purified by using IgD-Sepharose. The eluates from the beads were concentrated to 1/20th the volume of the original culture supernatants and applied to a TSK G3000 SWG column (Fig.  1 ). It appears that IgD-BF consist of two species of molecular weights approximately 78,000 and 37,000, respectively.
Cell Sources of IgD-BF. Normal spleen cells were depleted of Thy-1+ cells, Lyt-1+ cells, or Lyt-2+ cells, and each cell population was incubated overnight with IgD (0.4 ,g/ml). Culture filtrates were concentrated 4-fold and then incubated with IgD-Sepharose, and the eluate fraction from the beads were assayed for the presence of IgD-BF ( Table 4 One milliliter of affinity-purified IgD-BF was applied to the column, and proteins were eluted with DPBS. Distribution of IgD-BF in 3-ml fractions was determined by the ability of the fractions to inhibit formation of IgD rosettes. Arrows indicate elution volumes of bovine serum albumin (BSA), ovalbumin (OA), chymotrypsinogen (CH), and cytochrome c (CT). According to the manufacturer (Toyo Soda, Tokyo) of the column, these elution volumes correspond to molecular weights of 94,000, 54,000, 18,000, and 12,000, respectively. presence of IgD-BF (Table 5 ). The Fc8R+-depleted fraction failed to form IgD-BF. We also found that the depletion of tThy-l+ cells, Lyt-1+ cells, and Lyt-2+ cells comprised 89%, 79%, and 29%, respectively, of the T-cell-rich fraction, as determined by immunofluorescence. Only 3% of the Lyt-1+-depleted population was stained by anti-Lyt-1 antibody, and 5% of the Lyt-2+-depleted population was stained by anti-Lyt-2 antibody. (18) . The successful induction of IgD-BF formation in the present experiments may have been due to the fact that the monoclonal IgD employed was in the dimeric form (4) . Indeed, the elution volume of this protein from an AcA 34 column corresponded to that of dimeric IgD. Marcelletti and Katz (20) reported that interaction of IgE with FcR' B cells resulted in the formation of a soluble factor, which they called EIRT, and that this factor induced T cells to express FcR. According to their scheme, EIRT is also involved in the formation of IgE-BF by T cells IgD-BF. Indeed, rodent T-cell hybridomas 23B6 and 231F1 form IgE-BF upon incubation with homologous IgE (8, 22) . A mouse T-cell hybridoma, T2D4, produces IgG-BF upon incubation with IgG (5), whereas the same hybridoma produces IgA-BF when incubated with IgA (3).
The biologic role(s) of IgD-BF is unknown. However, injections of IgD into mice cause an enhancement of the primary immune response to T-cell-dependent antigens (23) , but this enhancement is not obtained in athymic nude mice. Since an injection of IgD also induced an apparent increase in Fc8R' T cells, Coico et al. (7, 24) suggested that these cells are responsible for the enhancement ofthe immune response. Indeed, they have shown that transfer of normal T cells exposed to IgD augmented the antibody response of the recipients. The formation of IgD-BF by Lyt-1l T cells exposed to IgD suggests strongly that the factors are involved in the augmentation of antibody responses. Previous studies on IgE-BF have shown that some of the factors selectively enhanced the IgE response, while the other type of IgE-BF suppressed the response (25) . Evidence has been presented that the factors regulate the differentiation of surface-IgE' B cells by binding to the cell surface IgE (26, 27) . Similarly, IgG-BF selectively suppress the IgG response (5), whereas IgA-BF selectively suppress the IgA response (3). It is known that the majority of B cells bear surface IgD. If the target of IgD-BF is actually surface-IgD' B cells, which are not committed for a certain isotype, it is conceivable that the factors may regulate the differentiation of these cells and affect the antibody response of all isotypes. It is known that both IgG-BF and IgE-BF are formed by antigenic stimulation of antigen-primed spleen cells (28, 29) . If IgD-BF are formed during the immune response, these factors may play an important role in the regulation of the antibody response.
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